Speaker

Ahmed Mousa

Chief Executive Officer, Vicore Pharma Holding

Ahmed Mousa, Chief Executive Officer at Vicore Pharma Holding, is speaking at 10th Antifibrotic Drug Development Summit 2026 (Boston, United States of America, 1–3 Dec 2026) in the session “From Epithelial Repair to Durable Benefit: AT2 Receptor Agonism as an Upstream Intervention in Fibrotic Disease”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Pharmacy & Pharmaceutical Sciences

Upcoming appearances

10th Antifibrotic Drug Development Summit 2026
1–3 Dec 2026Boston, United States of America
- SpeakerFrom Epithelial Repair to Durable Benefit: AT2 Receptor Agonism as an Upstream Intervention in Fibrotic Disease
- PanelPanel Discussion: Defining Cross-Indication Expansion Strategies to Maximize the Clinical & Commercial Potential of Antifibrotic TherapiesWith Alexander Barron, Marc Sze

More speakers at 10th Antifibrotic Drug Development Summit 2026

Rebecca Taub
Director, Madrigal Pharmaceuticals
Bernard Allan
Executive Director & Head of Liver Disease Research & Drug Discovery, GI-Ddu, Takeda Pharmaceutical
Jeffrey Bornstein
CMO, Mediar Therapeutics
Victor Bustos
Co-Founder & Chief Executive Officer, Refoxy Pharmaceuticals
Steve De Vos
Head of Translational Sciences, Fibrocor Therapeutics
Zoltan Derdak
Medical Director, Takeda Pharmaceutical

See all 20 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Ahmed Mousa, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].